| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 346 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 284 |
| 2 | TACROLIMUS OINTMENT 0.1% | 284 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 250 |
| 4 | MYCOPHENOLATE MOFETIL | 249 |
| 5 | GEMCITABINE HYDROCHLORIDE | 239 |
| 6 | ECULIZUMAB | 202 |
| 7 | GEMCITABINE | 185 |
| 8 | PREDNISONE | 174 |
| 9 | PREDNISOLONE | 150 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AESCULUS HIPPOCASTANUM WHOLE | 4 | 0.0533 |
| 1 | AGRIMONIA EUPATORIA | 4 | 0.0526 |
| 2 | CENTAURIUM ERYTHRAEA | 4 | 0.0519 |
| 3 | MITOMYCIN | 24 | 0.0066 |
| 4 | BELATACEPT | 29 | 0.0061 |
| 5 | BASILIXIMAB | 69 | 0.0058 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 45 | 0.0055 |
| 7 | CORTISOL | 2 | 0.0050 |
| 8 | PENTOSTATIN | 5 | 0.0048 |
| 9 | GEMCITABINE HYDROCHLORIDE | 239 | 0.0044 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 468 |
| 1 | Complement Inhibitor [EPC] | 207 |
| 2 | Platinum-based Drug [EPC] | 160 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 139 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 128 |
| 5 | Alkylating Drug [EPC] | 125 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 120 |
| 7 | Proteasome Inhibitor [EPC] | 116 |
| 8 | Microtubule Inhibitor [EPC] | 104 |
| 9 | Loop Diuretic [EPC] | 99 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 29 | 0.0061 |
| 1 | Complement Inhibitor [EPC] | 207 | 0.0037 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 17 | 0.0029 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 52 | 0.0023 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 5 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 28 | 0.0013 |
| 7 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 8 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 9 | Carnitine Analog [EPC] | 4 | 0.0011 |